Robust process development is essential in pharmaceutical manufacturing, optimizing drug discovery and ensuring regulatory ...

Harnessing the capabilities of the PhysioMimix Multi-organ System, the kit enhances lead optimization and preclinical testing pipelines, providing an all-in-one solution to generate predictive ...

The global market for Artificial Intelligence For Drug Development and Discovery Market has witnessed rapid growth, escalating from a valuation of $520 million in 2019 to a projected $4,815 million by ...

WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NOTV) (the “Company”), a leading contract research ...

The 2nd Covalent Drug Discovery and Development Summit returns as the central hub dedicated to every aspect of covalency from discovery to translation and clinical development, equipping 100+ global ...

A team of chemists from Scripps Research and Rice University has unveiled a novel method to simplify the synthesis of ...

Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a ...

Parse Biosciences, a leader in scalable single cell sequencing solutions, today announced the expansion of its Evercode BCR™ product line to enable applications in mice.